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A 32-year-old woman developed a unilateral cyst of
the duct of parotid gland 4 months after severe oral
involvement of drug-induced toxic epidermal necrolysis
(TEN). The pathomechanism leading to the TEN epi-
dermal destruction had presumably involved the salivary
epithelium as well, leading to the development of the
cystic lesion. The patient had low serum lipase levels, but
high serum amylase levels at the time of TEN. These
serological markers could represent a clue for the risk of
developing cystic lesions of the large salivary glands fol-
lowing TEN.
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A 32-year-old woman developed drug-induced toxic
epidermal necrolysis (TEN) 48 h after oral intake of
ibuprofen for headache. An erythematous rash covered
by blisters spread over 64% of the body surface. Severe
oral lesions were present associating oropharyngeal
erosions and bullae on the palate, tongue and cheek
mucosa. Ocular involvement consisted of conjunctival
synechiae and corneal ulcerations. The diagnosis of
TEN was confirmed by histological examination of a
skin biopsy taken 72 h after the initial cutaneous lesions.
A subepidermal blister was present with rare inflamma-
tory mononuclear cells scattered between confluent
necrotic keratinocytes. The patient was hospitalized
for 3 weeks in a burn unit where she was placed on a
fluidized bed. She benefited from supportive and anti-
septic measures, including daily bath. She was also
treated with cyclosporin IV (5 mg/kg/day) for five
consecutive days. Corticosteroids were not adminis-
tered. During that period of time, the amylase serum
values were severely and repeatedly increased during her
three-week hospitalization reaching a maximum of
998 IU/ml (normal upper limit: 90 IU/ml). By contrast,
the lipase serum values remained near to the upmost
normal range limit, occasionally and moderately above
it with a peak value of 225 IU/ml (upper limit of normal
values: 200 IU/ml). The patient was discharged from the
burn unit following complete cutaneous reepidermiza-
tion and healing of the oropharyngeal ulcerations.
Four months after TEN, she progressively developed
an oral swelling lesion nearby the left Stenon’s duct
orifice (Fig. 1). Histological examination of the surgi-
cally removed lesion showed a unilocular 0.9 cm dia-
meter well circumscribed cyst filled by some amorphous
material. The cyst wall was surrounded by a dense
fibrous connective tissue containing a mild inflamma-
tory cell infiltrate. The luminal surface of the cyst was
lined by an epithelium that exhibited a stratified,
squamous or columnar aspect according to the different
areas. A salivary duct cyst of the parotid was diagnosed.
Comments
Toxic epidermal necrolysis is a rare potentially lethal
disease characterized by sudden necrosis of the epider-
mis, and of the genital and oropharyngeal mucosae (1).
The only recognized cause of the disease is an adverse
reaction to drugs, especially sulfonamides, phenytoin,
non-steroidal antiinflammatory drugs and allopurinol.
Death rate due to TEN reaches about 30%. Pulmonary,
myocardial, osseous, renal and gastrointestinal long-
term sequelae have been reported (1). However, the
most commonly recognized long-term alterations
involve the eyes, skin, nails and the genital mucosae
(1). Conjunctival retraction, scars and sicca syndrome
with severe corneal lesions represent the main ocular
complications, sometimes resulting in a major handicap
for the patient. Cutaneous sequelae include keloidal
scars, alopecia, speckled eruptive melanocytic naevi and
hyper- or hypomelanosis. Residual nail dystrophies are
frequent. Genital involvement can lead to chronic vulvo-
vaginal synechiae. Oral and lip lesions usually heal
without complication, but strictures may develop in the
throat and œsophagus (1).
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Sjögren-like syndrome with xerostomia is also a
recognized complication of TEN (2). This condition
results from a chronic lymphocytic infiltration of small
salivary glands. However, post-TEN cystic lesion of the
large salivary glands has not been described so far. We
report one adult patient who developed unilateral cystic
lesion of the parotid duct following severe oral TEN
involvement. Ductal obstruction is thought to be the
main etiologic factor of this type of salivary cysts (3). No
malignant neoplasm, calculi or mucus plugs were found
in the presently reported patient. Hence, it is likely that
TEN sequelae were responsible for the ductal obstruc-
tion. The inflammatory infiltration of the cystic wall was
discrete and undistinguishable from that found in non-
TEN salivary ductal cysts. This suggests that the
formation of the cystic lesion probably resulted from
mechanical obstruction rather than from a post-TEN
persistent immunologic process.
Several destructive or cell-modifying immunopatho-
logical mechanisms found in TEN epidermis are prob-
ably also operative in the epithelial component of the
salivary glands. First, the L1 antigen (calprotectin), a
calcium-binding protein, is overexpressed in TEN epi-
dermis. It is thought to play an important role in TEN
epidermal apoptosis by disturbing Ca2+ homeostasis (4).
Normal or modified salivary gland duct cells also
express high amounts of calprotectin (5). In addition,
the pro-apoptotic CD 95 system (CD 95 receptor/FasR-
CD 95 ligand/FasL) has been reported to be involved in
TEN (4). Accordingly, the apoptosis-promoting mole-
cules FasR and FasL are strongly expressed in inflam-
matory conditions affecting ductal and acinar salivary
epithelial cells (6). Finally, dysregulation in tumor
necrosis factor a (TNF-a) system is likely involved in
cutaneous TEN pathogenesis (4). Ductal epithelial cells
also express TNF-a and its receptors in inflammatory
salivary glands (7). Moreover, TNF-a is able to upreg-
ulate FasL and FasR in these conditions (8).
Sustained high serum amylase levels combined with
low serum lipase levels were found in our patient. The
salivary glands and the pancreas are the two major
sources of amylase in humans. As the lipase levels were
close to normal in our TEN patient, a pancreatic
involvement is unlikely. Hence, the prolonged elevation
in serum amylase was probably due to a salivary
involvement. In TEN, the incidence of hyperamylasemia
is over 30% of the patients, and salivary hyperamy-
plasemia is predominant (9). Hyperamylasemia reflects
the extent in mucosal membrane involvement. It seems
to have a predictive value of post-TEN Sjoegren-like
sicca syndrome (9). It is also possible that high serum
amylase levels coupled with low lipase serum levels
could have a predictive value for the development of
post-TEN lesions of the large salivary glands. Indeed,
we have another record in our files of a Warthin tumor
of the parotid gland diagnosed 10 years following severe
TEN. The serum amylase dosages were elevated at the
time of skin blistering while serum lipase were in the
normal range of values.
In conclusion, we report a TEN patient in whom a
cystic lesion developed subsequently in the parotid gland
apparatus. It is suggested that such a lesion represents a
possible long-term consequence of TEN severely affect-
ing the oral cavity.
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Figure 1 Post-toxic epidermal necrolysis duct cyst of the parotid.
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